Author Archives: lmo032

Announcement of Erasmus Mundus Joint Masters Degrees

Erasmus-plus_logoDivision of Student Affairs has announced funding for Erasmus Munduns, Joint Master Degrees (EMJMD), with application deadline March 4, 2015. Institutes interested in applying for funding should apply via the faculty, who will provide a new application to Division of Student Affairs.   Any plans regarding the establishment (or termination) of academic study programmes must also be included in the institute’s education reports. Click here for announcement letter with more information(in Norwegian). Click here for complete program guide.

COST: New research networks – medical and health related research

Cost logo bildeCOST is a European network organization where most European countries participate.  An important task for COST is to promote European research collaboration by initiating scientific networks.  It has now been decided that COST-actions related to COST’s committee “Biomedicine and Molecular Biosciences (BMBS)” will be initiated.  Click here for more information about this actions.  For more information about COST-actions in general, click here.  For application form, click here.  Note: All links are in Norwegian.  For general information about COST in English, see

NEW K1/K2 SEMINAR

We wish to invite you all to the next monthly K1/K2 Seminar Series!

Title: “B-cell depletion in chronic fatigue syndrome”

Held by Øystein Fluge, Senior Scientist, Department of Clinical Science

When: Wednesday, December 3rd, 14:15-15:00.

Where: Main Auditorium, 3rd floor, Sentralblokken.

Chair: Roland Jonsson

Abstract: Chief Physician and Senior Scientist Øystein Fluge, together with colleague Olav Mella, study the effects of the cancer medicine Rituximab on ME-patients, also known as Chronic Fatigue Syndrome. This year they have initiated a double blind study in order to test Rituximab on patients. At this seminar Øystein Fluge will talk about his exciting work, about Chronic Fatigue Syndrome and the effects of Rituximab.

Announcement of scolarships from Pasteur Legatet 2014

On December 27, 2104, The Pasteur Foundation will award scholarships to Norwegian scientists who intend to study a topic related to infectious agents, chemistry or the fermentation industry. Allocation of funding is preferably awarded young, active and promising researchers, below the doctoral level.
For more information (In norwegian)

Deadline December 15th.

Outstanding award to PhD-Candidate at K2

utstanding award til Ph.D.-kandidatAs part of the annual meeting of American College of Rheumatology (ACR) in Boston, USA, PhD-Candidate/LIS-doctor Maria Boge Lauvsnes was awarded the Sjögren’s Syndrome Foundation’s Outstanding Abstract Award. Through her work – Hippocampal Atrophy Is Associated with Anti-NR2 Antibodies in Patients with Systemic Lupus Erythematosus and Primary Sjögren’s Syndrome – she has shown that a type of anti-NMDA receptor antibodies (anti-NR2 antibodies) cause atrophy of the brain structure hippocampus in humans with the immunological diseases SLE and primary Sjögren’s syndrome. This has been confirmed in animal models, which have revealed that anti-NR2 antibodies cause neuronal death of hippocampus in mice.

Such antibodies are associated with cognitive failure in both SLE and primary Sjögren’s syndrome, and they may constitute a general mechanism for cerebral affection with immunopathies.

Maria Boge Lauvsnes works for the Clinical Immunological Research Group at Stavanger University Hospital

Cecilie Svanes awarded COPD Prize from LHL

cecile_svanes_1Yesterday, Professor Cecilie Svanes (Centre for International Health at Department of Global Health and Primary Care) received the COPD Prize from The National Organization for Heart- and Lung Disease (LHL). Svanes is, among other things, currently researching how the living conditions of grandparents and parents may influence the development of asthma and Chronic obstructive pulmonary disease (COPD) in children. Read more here: (in Norwegian)